Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores
Status:
Terminated
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess if docetaxel and cytoxan can shrink the size of your
breast tumor and allow you to preserve your breast or have less extensive surgery on your
breast. Additionally, by receiving chemotherapy before surgery, the investigators will be
able to determine if your cancer is responsive to chemotherapy.